PharmTech News

Articles

German biotech ARTES and Iranian biopharma manufacturer BioSun will develop an HPV vaccine.

ARTES and BioSun Collaborate on HPV Vaccine

The company invested more than €250 in production in China.

Merck KGaA Invests in Pharma Production in China

CFDA granted Pfizer China approval for the company’s Prevenar 13 vaccine.

Pfizer China Receives Approval for Prevenar 13

Astellas will acquire Ganymed and its portfolio of ideal monoclonal antibody candidates.

Astellas to Acquire Ganymed

Bellicum and Ospedale Pediatrico Bambino Gesù will collaborate on preclinical and clinical development of CAR-T and TCR therapeutics.

Bellicum Collaborates on CAR-T Therapies

Oxford Genetics has secured a GBP1 million capital from investment group Mercia Technologies to support its growth strategy in delivering new services for cancer-fighting gene-therapy technologies.

Oxford Genetics Secures GBP1 Million Investment for Gene Therapy Technologies

Teva and IBM expanded their partnership to focus on drug development and chronic disease management.

Teva and IBM Expand Partnership

The collaboration follows the signing of a cooperative research agreement between Sanofi Pasteur, Fiocruz, and WRAIR.

Sanofi Pasteur Collaborates with WRAIR, Fiocruz on Zika Vaccine Development

Caribou and JAX entered into a license agreement for Caribou’s CRISPR-Cas9 gene editing technology.

Caribou Biosciences and the Jackson Laboratory Enter into License Agreement for CRISPR-Cas9

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Kaléo announced on Oct. 26, 2016 that the company will reintroduce the AUVI-Q (epinephrine injection) to the United States market during the first half of 2017. AUVI-Q is a prescription epinephrine autoinjector used to treat anaphylaxis. The autoinjector includes an automatically retractable needle and a voice prompt system that guides the user through delivery.

Bio/Pharma News